Nanobiotix: Clinical Trials

7 trials sponsored by Nanobiotix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 5 Phase 1, 4 Phase 2, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 2, Active not recruiting 1, Completed 1, Recruiting 1
Phase 24Terminated 2, Completed 1, Recruiting 1
Not applicable1Unknown 1
Phase 31Completed 1

Follow Nanobiotix: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
NBTXR3 - Locally-Advanced Non-Small Cell Lung Cancer
Phase 1 / Phase 2RecruitingM.D. Anderson Cancer Center402026-03-272026-09-18
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
NBTXR3, SABR, Nivolumab - Radiotherapy, Immunotherapy
Phase 1Active not recruitingNanobiotix1452019-01-162025-10-24
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
NBTXR3 activated by IMRT only, NBTXR3 activated by Brachytherapy & IMRT - Prostate Cancer
Phase 1 / Phase 2TerminatedNanobiotix52017-11-152021-05-10
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
NBTXR3, IL or IA injection + SBRT - Liver Cancer
Phase 1 / Phase 2TerminatedNanobiotix232016-01-282021-05-10
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall
NBTXR3, Radiation therapy - Adult Soft Tissue Sarcoma
Phase 2 / Phase 3CompletedNanobiotix1802015-03-032021-04-06
NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx
NBTXR3 activated by IMRT - Head and Neck Cancer
Not applicableUnknownNanobiotix752014-01-032022-12-29
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity
NBTXR3 - Adult Soft Tissue Sarcoma
Phase 1CompletedNanobiotix222011-10-012020-10-06

Conditions studied

Mouth Neoplasms (2)  ·  Oropharyngeal Neoplasms (2)  ·  Sarcoma (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Triple Negative Breast Neoplasms (1)

Interventions

Nivolumab (1)  ·  Radiosurgery (1)  ·  Radiotherapy (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  pembrolizumab (1)

Countries

France (4)  ·  United States (3)  ·  Hungary (2)  ·  Poland (2)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Norway (1)  ·  Philippines (1)  ·  Romania (1)  ·  South Africa (1)

Top investigators

Adam Dicker, MD (1)  ·  Aileen Chen, MD (1)  ·  Pavel Tyan, MD (1)

Results publications

PMID 31296491, PMID 33607477, PMID 41609775